We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
(+18%)
Cap. Flow
+$2.78B
Cap. Flow
% of AUM
12.74%
Top 10 Holdings %
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$363M |
| 2 |
Tencent Music
TME
|
+$184M |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$182M |
| 4 |
Baidu
BIDU
|
+$146M |
| 5 |
Gaotu Techedu
GOTU
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$204M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$189M |
| 3 |
Zoetis
ZTS
|
+$182M |
| 4 |
Guardant Health
GH
|
+$136M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.03% |
| 2 | Consumer Discretionary | 13.15% |
| 3 | Technology | 10.68% |
| 4 | Financials | 9.81% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKIC
626
DELISTED
Sports Ventures Acquisition Corp. Class A Ordinary Shares
AKIC
| $7.23M | 0.03% |
+751,815
| New | +$7.42M |
|
627
Uranium Energy
UEC
$4.71B
| $7.22M | 0.03% |
+2,526,232
| New | +$5.51M |
|
|
628
Guardant Health
GH
$19.5B
| $7.22M | 0.03% |
47,291
-899,591
| -95% | -$136M |
|
629
Synchrony
SYF
$23.7B
| $7.19M | 0.03% |
176,754
-90,364
| -34% | -$3.48M |
|
630
Ventas
VTR
$48.9B
| $7.14M | 0.03% |
+133,869
| New | +$6.87M |
|
|
NVEE
631
DELISTED
NV5 Global
NVEE
| $7.12M | 0.03% |
+294,892
| New | +$7.03M |
|
632
Outset Medical
OM
$74.9M
| $7.11M | 0.03% |
8,716
-7,657
| -47% | -$5.91M |
|
633
StepStone Group
STEP
$3.48B
| $7.08M | 0.03% |
+200,619
| New | +$7.06M |
|
634
Henry Schein
HSIC
$9.74B
| $7.05M | 0.03% |
101,778
-149,933
| -60% | -$10.1M |
|
635
Fomento Económico Mexicano
FMX
$43.3B
| $7.04M | 0.03% |
93,417
+59,253
| +173% | +$4.31M |
|
636
T. Rowe Price
TROW
$25B
| $7.04M | 0.03% |
+40,995
| New | +$6.72M |
|
|
IRAAU
637
DELISTED
Iris Acquisition Corp Units
IRAAU
| $7.04M | 0.03% |
+700,000
| New | +$7.13M |
|
638
nCino
NCNO
$1.81B
| $7.02M | 0.03% |
105,259
+97,994
| +1,349% | +$6.99M |
|
639
Chewy
CHWY
$8.54B
| $7.01M | 0.03% |
82,700
-81,885
| -50% | -$7.97M |
|
|
RMGCU
640
DELISTED
RMG Acquisition Corp. III Unit
RMGCU
| $6.97M | 0.03% |
+700,505
| New | +$7.28M |
|
|
SWETU
641
DELISTED
Athlon Acquisition Corp. Unit
SWETU
| $6.97M | 0.03% |
+704,794
| New | +$7.26M |
|
642
Capri Holdings
CPRI
$1.77B
| $6.94M | 0.03% |
136,072
-126,401
| -48% | -$5.95M |
|
|
BLUE
643
DELISTED
bluebird bio
BLUE
| $6.93M | 0.03% |
17,740
+15,254
| +614% | +$7.51M |
|
644
CALL
Walmart Inc
WMT
$871B
| $6.93M | 0.03% |
+153,000
| New | +$7.09M |
|
645
Texas Roadhouse
TXRH
$12.7B
| $6.92M | 0.03% |
+72,175
| New | +$6.31M |
|
646
TriSalus Life Sciences
TLSI
$259M
| $6.91M | 0.03% |
+716,086
| New | +$7.26M |
|
|
CANG
647
Cango Inc
CANG
$69.3M
| $6.9M | 0.03% |
82,138
+71,938
| +705% | +$7.32M |
|
648
PUT
Target
TGT
$62.1B
| $6.89M | 0.03% |
+34,800
| New | +$6.51M |
|
649
Lyft
LYFT
$5.39B
| $6.87M | 0.03% |
+108,687
| New | +$6.07M |
|
650
Adaptive Biotechnologies
ADPT
$3.56B
| $6.86M | 0.03% |
+170,442
| New | +$9.23M |
|
Similar funds
Marshall Wace's Q1 2021 Portfolio in Review
As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.
- Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
- Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
- Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
- Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
- Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
- Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.
Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.